Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest HPV Stories

2012-09-20 02:27:56

SAN DIEGO, Sept. 20, 2012 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) and Strand Life Sciences Pvt Ltd., of Bangalore, India, completed their agreement to validate and commercialize Trovagene's proprietary urine-based Human Papillomavirus (HPV) test for clinical diagnostic and carrier screening use. Trovagene's urine-based HPV test is designed to allow for completely non-invasive HPV carrier screening. Strand's initial target market is an estimated population of over 450 million women...

HPV Test Combination Better Than Viral DNA Test Alone
2012-09-19 09:44:56

Connie K. Ho for redOrbit.com — Your Universe Online Two new studies published in the journal of the American Association for Cancer Research discovered that assessments of the human papillomavirus (HPV) that test for a single DNA biomarker alone are a weak indicator for determining the risk of HPV-driven head and neck cancers. On the other hand, the studies point to a combination of genetic markers that may provide a more robust test. Past research has found that HPV can lead to...

2012-09-11 02:28:31

MOUNTAIN VIEW, Calif., Sept. 11, 2012 /PRNewswire/ -- Based on its recent analysis of the molecular diagnostics market, Frost & Sullivan recognizes IncellDx with the 2012 North American Frost & Sullivan Award for Product Leadership for its pioneering cervical cancer testing technology, a methodology which holds the promise of decreasing the number of unnecessary, painful, and expensive invasive testing procedures. Numerous clinical studies evaluating the company's HPV OncoTect(®)...

2012-08-30 06:25:40

MADISON, N.J., Aug. 30, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer. The test is designed to help physicians identify women who are at increased risk of developing malignancy, unless treated, after receiving unclear results for cervical...

Should HPV Vaccines Be Given To Men?
2012-08-08 12:33:33

Connie K. Ho for redOrbit.com — Your Universe Online Color blindness. Menstrual cycle. Males and females differ in a number of areas when it comes to the human body, including vaccinations offered. A new study sparked a debate in the public health sphere when it examined whether the vaccination against human papilloma virus (HPV) should be given to males. To begin, researchers from the University of Southern California and University of California, Los Angeles (UCLA) David Geffen...

2012-08-01 10:34:07

High-risk human papilloma virus found with Epstein Barr virus Two common viruses known to be associated with human cancers are both present — and may even be collaborating with each other - in most male prostate cancers, a new study suggests. The research involved examination of 100 specimens of normal, malignant and benign prostate samples from Australian men. It revealed that both the human papilloma virus (HPV) and Epstein Barr virus (EBV) were present in more than half of...

2012-07-25 09:35:14

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18. Is there a chance that the increased number of people vaccinated might result in an increase of other types of HPV that cause cancer? A UNC-led international team of scientists studied this question in a group of 2228 Kenyan men as a...

2012-07-23 20:37:17

Compared to the general population, HIV-positive women have a high risk of cervical cancer and thus are advised to undergo more frequent screening tests. This creates a burden for HIV-positive patients and the health care system, leading to frequent biopsies, which often do not reveal clinically relevant disease. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that HIV-positive women may be able to use new methods that can help to safely...

2012-07-23 13:40:23

HIV-infected and uninfected women with normal cervical cytology (Pap test) and a negative test result for oncogenic (tumor inducing) human papillomavirus DNA at study enrollment had a similar risk of cervical pre-cancer and cancer after 5 years of follow-up, according to a study in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Howard D. Strickler, M.D., M.P.H., of the Albert Einstein College of Medicine of Yeshiva University, New York, presented the findings of the study at a JAMA...

2012-07-22 06:20:11

BRONX, N.Y., July 22, 2012 /PRNewswire-USNewswire/ -- Compared to the general population, HIV-positive women have a high risk of cervical cancer and thus are advised to undergo more frequent screening tests. This creates a burden for HIV-positive patients and the health care system, leading to frequent biopsies, which often do not reveal clinically relevant disease. (Logo: http://photos.prnewswire.com/prnh/20120531/DC16559LOGO) A new study by researchers at Albert Einstein College of...


Latest HPV Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »